Hetero is a prominent Indian generic pharmaceutical company and the largest global manufacturer of anti-retroviral medications. Founded in 1993 by Dr. B. Partha Saradhi Reddy, Chairman of Hetero Group of Companies, the organization has grown into India’s largest privately held pharmaceutical firm over the last three decades. With a legacy spanning 30 years, Dr. Reddy has guided Hetero’s transformation into a global leader in anti-retroviral drug production.
We are recognized globally for our leadership in manufacturing essential Active Pharmaceutical Ingredients (APIs) and high-quality generic formulations, with a footprint in over 140 countries. Leveraging three decades of expertise in the pharmaceutical industry, we are committed to delivering therapies that combine scientific innovation with technology to enhance health outcomes worldwide.
At Hetero, our mission is to transform scientific research into life-changing solutions, improving lives through accessible healthcare across the globe. Backed by 30 years of industry experience, we strive to advance patient care by turning science and innovation into effective treatment solutions. With operations in more than 140 countries, Hetero is a trusted name in APIs and generics, dedicated to improving global health.
